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Abstract Bacillus cereus is a major food-born pathogen
in Taiwan and its major syndromes include vomiting, fever
and diarrhea. To minimize the possibility of exposing con-
sumers to pathogenic B. cereus, this study develops a rapid
and sensitive assay that utilizes immunoliposomal nanove-
sicles (IMLNs) and immunomagnetic beads (IMBs). In this
work, Xuorescent dyes (sulforhodamine B)-loaded IMLNs
were employed to increase the detection signal; anti-B.
cereus antibody-conjugated IMBs were applied to capture
B. cereus in samples. Hence in this assay, a sandwich com-
plex was formed as “IMBs-B. cereus-IMLNs”. The optimal
IMLNs had a diameter of 300 nm with a conjugated anti-
body molar percentage (mol%) of 0.25 mol%. The limit of
detection (LOD) of this developed assay reaches 10 CFU/
mL of B. cereus with the false negative value as zero in 20
parallel assays in milk samples. To evaluate the speciWcity
of this assay, nine Gram positive and negative bacteria
were tested and found to cause no signiWcant interference
problems. In conclusion, this study elucidates the feasibility
of using a novel IMB/IMLN assay for detecting B. cereus
and its LOD without pre-enrichment could amount to
10 CFU/mL within 4 h.
Keywords Bacillus cereus · Immunoliposomal 
nanovesicles · Immunomagnetic beads
Introduction
Bacillus cereus has been recognized as a foodborne patho-
gen since 1955 [1] and is classiWed as emesis and diarrhea
forms. The emetic form is characterized by nausea, vomit-
ing and abdominal cramps with an incubation period of
1–6 h [2]. Cereulide is the cause of emesis, and is a cyclic
heat-stable dodecadepsipeptide toxin [3]. The diarrheal
form causes abdominal cramps and diarrhea with an incu-
bation period of 8–16 h [4]. These symptoms are mediated
by heat-liable enterotoxins during the vegetative growth of
B. cereus in the small intestine [5], three of which have
been identiWed; they are hemolysin BL (HBL) [6], non-
hemolytic enterotoxin (Nhe) [7] and cytotoxin-K [8].
Bacillus cereus is a common soil inhabitant and so is pres-
ent in a wide range of foods. The emetic form has been
associated with fried rice from Chinese restaurants, maca-
roni and cheese [9, 10]; the diarrheal form is mostly linked
to beans, cereals, spices, seasoning mixes, potatoes, meats
and milk [11, 12]. In particular, B. cereus contamination in
milk is notable since it causes not only spoilage of the milk
but also human diseases [13, 14].
To indentify eVectively the contamination of food by
B. cereus, various methods have been developed for
detecting B. cereus, B. cereus spores or B. cereus entero-
toxins. A sensitive chemical assay is employed to detect
cereulide based on high-performance liquid chromatog-
raphy with ion trap mass spectrometry (LC-MS) [15].
DNA-based methods, such as polymerase chain reaction
(PCR) and real-time PCR, have been developed for the
detection of cereulide [16], enterotoxins of B. cereus [17,
18], or B. cereus [19]. Furthermore, immunoassays, such
as enzyme-linked immunosorbant assay (ELISA) and
colony immunoblot assay, have been developed to detect
the diarrheal toxins [20–22], a 28.5 kDa cell surface
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Xagella antigen [26]. Conventional procedures for
detecting B. cereus generally take more than 3 days to
complete, whereas LC-MS or PCR assays can rapidly
and precisely detect toxins with high sensitivity, but
require expensive equipment. Therefore, rapid, cost-
eVective and sensitive assays for detecting B. cereus must
be developed.
Immunomagnetic separation (IMS) is a procedure that
utilizes IMBs as capture reagents. It has been developed
for microbial isolation and identiWcation. The use of IMS
in assays is increasing because magnetic handling is
quick, eYcient and only gently aVects the target analytes.
Furthermore, various bioreactive molecules can be conju-
gated to the IMB surface for the immunoprecipitation
[27], isolation and identiWcation of biomolecules (such as
cells, pathogens and proteins) [28–30], or to improve the
resolution of magnetic resonance imaging (MRI) [31]. In
this study, protein-A magnetic beads are applied to conju-
gate rabbit anti-B. cereus antibody to form IMBs captur-
ing B. cereus in samples. During the assay advance, the
IMBs can more evenly distribute in the sample to increase
the binding surface, and to directly capture, concentrate
to replace with pre-enrichment of bacteria and isolate tar-
gets without the centrifugation. Protein A is a cell wall
component of Staphylococcus aureus and binds speciW-
cally and strongly to the fragment crystallizable region
(Fc region) of immunoglobulin at neutral or slightly basic
pH values [32].
Liposomal nanovesicles can be used as labeling
reagents because of their ability to amplify an assay signal
immediately and reduce drastically the assay time. Liposo-
mal nanovesicles are spherical particles that are composed
of phospholipid bilayers around an aqueous cavity [33],
inside which hundreds of thousands of Xuorescent dye
molecules, sulforhodamine B (SRB), are captured [34].
When liposomal nanovesicles are used in Xow-injection
analysis, ELISA, or magnetic bead assay, the signals can
be immediately ampliWed by releasing the encapsulated
SRB molecules by adding detergents, such as Triton X-
100 or n-octyl--D-glucopyranoside (n-OG) [35, 36].
Moreover, liposomal nanovesicles are very stable [37] and
numerous biological molecules can be conjugated on the
liposomal surface to make the liposomal nanovesicles tar-
geted. All of these characteristics make liposomal nanove-
sicles an optimal labeling reagent in bioassays [38].
Therefore, the goal of this study is to develop a rapid and
sensitive method based on the use of IMBs as the capture
reagent to harvest speciWcally B. cereus in samples, fol-
lowed by the use of anti-B. cereus antibody tagged IMLNs




Milk was bought from a local supermarket (Taichung,
Taiwan). Magnetic beads coupled with protein A and the
DynaMag™-2 magnets were bought from Invitrogen Corp.
(Carlsbad, CA, USA). Dipalmitoyl phosphatidylethanol-
amine (DPPE), dipalmitoyl phosphatidylcholine (DPPC) and
dipalmitoyl phosphatidylglycerol (DPPG) were purchased
from NOF Corp. (Tokyo, Japan). The Mini Extruder was
purchased from Avanti Polar Lipid, Inc. (Alabaster, AL,
USA), and the 0.2 and 0.4 m pore size Nuclepore Track-
Etch membranes were purchased from Whatman (Clifton,
NJ, USA). Bacteria cultures were purchased from the Food
Industry Research and Development Institute (Hsinchu, Tai-
wan). Chloroform and methanol were bought from Merck
(Darmstadt, Germany). Sulforhodamine B, dimethyl sulfox-
ide (DMSO), N-ethylmaleimide (NEM), hydroxylamine
hydrochloride, succinimidyl-S-acetylthioacetate (SATA),
Sephadex G-25, Sephadex G-50, Sepharose CL-4B, n-octyl-
-D-glucopyranoside (n-OG), sodium sulWte, cholesterol,
HEPES, EDTA, Tween-20, Triton X-100, and other chemi-
cals were purchased from Sigma (St. Louis, Missouri, USA).
Rabbit anti-B. cereus antibodies were kindly provided by Dr.
Chen CH, of the Food Industry Research and Development
Institute (Hsinchu, Taiwan).
Preparation of immunomagnetic beads
Protein A magnetic beads and anti-B. cereus antibodies
were mixed for 10 min at room temperature with gentle
shaking. After they were placed on a magnet holder, the
supernatant was removed from the tube. The beads were
washed twice using 0.1 M phosphate buVered saline (PBS)
to remove the non-attached antibodies. Finally, they were
resuspended in PBS to obtain immunomagnetic beads
(IMBs), which were kept at 4 °C.
Preparation of immunoliposomal nanovesicles
ATA-liposomal nanovesicles were prepared by hydration/
freezing and thawing/extrusion. First, DPPE–ATA was pre-
pared by conjugating DPPE to SATA, as described elsewhere
[39]. A mixture of DPPC, DPPG, cholesterol and DPPE–
ATA in a molar ratio of 45.4:4.5:46:4 was dissolved in a
solution of 6 mL chloroform, 1 mL methanol, and 0.5 mL
DPPE–ATA, and dried in a rotary evaporator. The dried lipid
Wlm was hydrated by adding 3 mL of 0.15 M SRB solution
(in 0.02 M HEPES, pH 7.5, and osmolality 530 mmol/kg).
The lipid solution was processed with Wve freeze-and-thaw
cycles, and then extruded through polycarbonate membranes123
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removed by gel Wltration using a Sephadex G-50 column with
Tris-buVered saline (TBS: 0.02 M Tris with 0.15 M NaCl,
0.01% NaN3, and pH 7.5) containing sucrose (osmolality
530 mmol/kg).
Anti-B. cereus antibody-tagged IMLNs, were made by
conjugating maleimide activated antibodies to sulfhydryl
liposomal nanovesicles, produced from ATA liposomal
nanovesicles by deprotection with hydroxylamine, with a
starting amount (mol) of antibodies as a percentage of the
amount of surface lipids of 0.125, 0.25 and 0.5 mol%. Each
reaction was incubated overnight at 4 °C. After the reaction
had been quenched using 1 M NEM for 4 h at room
temperature, IMLNs were separated from unbound anti-
bodies on a Sepharose CL-4B column with TBS (osmolal-
ity: 530 mmol/kg) as the running buVer.
The phospholipid concentration of IMLNs was deter-
mined by Bartlett’s phosphorus assay [40], and the size of
the IMLNs was measured by laser diVraction particle size
analysis in an LS particle size analyzer (Coulter ScientiWc
Instruments, Hialeah, FL, USA). The Bio-Rad protein
assay was used to determine the antibody concentration
using rabbit immunoglobulin G (IgG) as the standard. The
conjugation eYciency of antibody to the liposomal surface
was calculated as [Ab]a £ 100/[Ab]0, where [Ab]0 is the
starting amount of antibodies, and [Ab]a is the amount of
tagged antibodies.
Strains and their growth conditions
Table 1 presents the ten major foodborne bacterial species
employed herein as reference strains to evaluate the speci-
Wcity of the assay. Bacillus cereus, S. aureus, Bacillus
subtilis, Alcaliomes faecalis, Enterobacter cloacae, Pseudo-
monas aeruginosa, Escherichia coli, Escherichia faecalis
were grown in tryptone soya broth (TSB), and Listeria mon-
ocytogenes and Yersinia enterocolitica were grown in brain
heart infusion broth (BHI broth) for 14 h at 37 °C with
shaking. Cultures were serially diluted using 0.064 M
phosphate buVer (PB) and bacterial concentrations were
determined by adding 0.1 mL of 10¡6 or 10¡7 dilution to
tryptone soya agar (TSA) plates; colonies were counted
visually after the plates had been incubated at 37 °C for
18–24 h.
Assay performance
All bacterial strains whose IMB/IMLN sensitivity and
speciWcity were to be analyzed were grown at 37 °C over-
night in the optimal broth. The cells were collected by cen-
trifugation at 8,500 rpm for 10 min and resuspended in PB;
their concentration was then adjusted to the appropriate
concentration. The numbers of colony-forming units (CFU)
per milliliter of each culture were determined after serial
dilution (1:10) in the sterile PB. Triplicate 0.1 mL samples
of each dilution, used to spiked samples, were plated onto
TSA plates. The plates were incubated overnight at 37 °C
to count the colonies.
The assay used sterilized commercial skimmed milk.
Samples of fresh retail milk (10 mL) were spiked with B.
cereus at Wnal concentrations of 10–105 CFU/mL, and
placed in a refrigerator for 30 min. The unspiked sample
(0 CFU/mL) was utilized as a negative control. IMBs were
initially blocked with 5% (w/v) BSA for 10 min at room
temperature. After the supernatant had been removed,
IMBs were resuspended and reacted with 1 mL of bacteria
culture in a 2 mL eppendorf on a rocking platform for 1 h at
37 °C, to capture B. cereus. The eppendorfs were removed
from the incubator and placed in the magnetic holder for
3 min. Subsequently, the supernatant was aspirated from
the tube with a vacuum aspirator and the beads were
washed twice using 1 mL of Tris-buVered saline that con-
tained 0.05% Tween 20 (TBST). The IMB-B. cereus pellet
was resuspended in 100 L of IMLN solution, and contin-
ued to be incubated on a rocking platform for one hour at
37 °C, before it was magnetically separated and the super-
natant was removed. The resulting pellet was washed with
TBST; the supernatant was removed, and Wnally 100 L of
30 mM n-OG in TBS was added to each tube with a 5-s
vigorous shaking to release the enraptured SRB molecules.
The resulting supernatant that contained released SRB mol-
ecules was transferred to a black 96-well microtiter plate.
The Xuorescent signal of each well was immediately mea-
sured by a Xuorescence ELISA reader with an excitation
wavelength of 540 nm and an emission wavelength of
590 nm; and a dose-response curve was plotted using a
serial dilution of B. cereus in the milk samples. The LOD
for B. cereus was determined from the dose-response curve
as the concentration of B. cereus that corresponded to the
mean (plus three SDs) Xuorescence signal of the unspiked
sample. In order to evaluate the false negative value of this
Table 1 Bacteria strains used in this study
Bacteria Source
Bacillus cereus ATCC 11778
Staphylococcus aureus ATCC 10781
Bacillus subtilis DB430
Alcaliomes faecalis ATCC 10828
Listeria monocytogenes ATCC 14845
Enterobacter cloacae ATCC 10401
Yersinia enterocolitica ATCC 13999
Pseudomonas aeruginosa ATCC 10944
Escherichia coli DH5
Escherichia faecalis ATCC 10789123
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spiked with 10 CFU/mL of B. cereus 11,778 in the sterile
PB and sterile skimmed milk, respectively. Subsequently,
each sample was analyzed by the optimized assay.
Results and discussion
Maximizing the binding capacity of protein 
A magnetic beads
In this study, the surfaces of protein A magnetic beads were
applied to conjugate anti-B. cereus antibodies to form
IMBs as capture reagents. Since protein A speciWcally
binds to the Fc region of antibody molecules, their interac-
tion does not interrupt the antigen binding ability, and so
has contributed to the great development of immunological
applications [41]. Since the binding of anti-B. cereus anti-
body to protein A in solution is an equilibrium reaction, the
reaction volume was kept low to yield high concentrations
of beads and antibodies and thereby capture as many anti-
bodies as possible. Figure 1 plots the amounts of antibodies
captured at diVerent concentrations of rabbit anti-B. cereus
antibodies (50–200 g/mL) to maximize the binding capac-
ity of protein A magnetic beads without wasting antibodies.
The amount of antibody binding was determined by Bio-
Rad protein assay. The amount of antibody adsorbed
increased as the antibody concentration increased to
175 g/mL, and then remained at »17 g as the antibody
concentration increased further. Figure 1 indicates that at a
conjugated antibody amount of 17 g, the surface area of
protein A magnetic beads available for binding to antibod-
ies became saturated. Therefore, the optimal binding capac-
ity was reached when 17 g of antibody from 200 L of
175 g/mL anti-B. cereus antibodies were captured by
100 L of protein A magnetic beads.
Optimizing the components of wash buVer
To reduce the degree of nonspeciWc interactions and then
increase the sensitivity of immunoassays, a wash buVer is
typically applied after the antigen–antibody interactions
have occurred. In this work, Tris-buVered saline that con-
tained Tween-20 (TBST) was used as the base to optimize
the components of the wash buVer. The eVects of the pH
value (6, 7, and 8) and the solute (sodium chloride versus
sucrose) in the wash buVer were investigated. To stabilize
the liposome by equilibrating the internal and external
osmolality of liposomes, the osmolality of all solutions
used in this developed assay was adjusted to 530 mmol/kg.
Hence, sodium chloride or sucrose was used to adjust
osmolality of the wash buVer. Figure 2 presents the inten-
sity of Xuorescence signal and signal-to-noise ratios (S/N;
the intensity of Xuorescence signals of spiked samples/the
intensity of Xuorescence signals of unspiked samples) of
various wash buVers. Even though the wash buVers that
contained sodium chloride yielded a stronger Xuorescence
signal (80,000–40,000 AU) from samples that had been
spiked with 108 CFU/mL B. cereus than the wash buVers
that contained sucrose, they also yielded higher background
signals (60,000–40,000 AU) for the unspiked samples.
Therefore, the wash buVers that contained sucrose had bet-
ter S/N ratios (11.9–13.5) than those that contained sodium
chloride, whose S/N ratios were only 1.0–1.3. Additionally,
the non-speciWc binding decreased as the pH value of the
wash buVers increased, regardless of whether sodium chlo-
ride or sucrose was added. Among these six wash buVers,
the TBST with sucrose at pH 8 had the greatest S/N (13.5)
and was therefore selected in the Wnal assay.
Fig. 1 Amount of antibody captured by protein A magnetic beads as
a function of increase in concentration of antibody. One hundred
microliter of protein A magnetic beads was incubated with 200 L of
anti-B. cereus antibody for 10 min at room temperature
Fig. 2 EVect of pH value and solutes in wash buVer on Xuorescence
signal in detecting B. cereus in an IMB/IMLN Xuorescence assay.
Osmolality of TBST buVer was adjusted to 530 mmol/kg using NaCl
or sucrose, and then pH was adjusted to 6, 7 or 8123
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The purpose of using IMB herein is to concentrate B.
cereus in samples selectively for quantiWcation. To reduce
the cost of materials and perform a sensitive assay, the
amount of IMBs was then optimized. First, various IMB
volumes (5, 10, 20 or 40 L) in 1 mL samples that were
spiked with 108 CFU/mL of B. cereus were tested, to deter-
mine the minimal volume of IMBs that suYces to capture
the entire amount of 1 mL of 108 CFU B. cereus. Five
microliter of IMBs captured 99.5% of the B. cereus popula-
tion (data not shown). In the next step, the optimal amount
of IMB that maximized the S/N ratio was found. Figure 3
plots the intensity of Xuorescence signals and the S/N ratios
of various IMB volumes with unspiked and spiked samples.
BrieXy, after the supernatants of IMBs on the magnetic sep-
aration holder were removed, 1 mL of unspiked or spiked
(108 CFU/mL) samples were added and incubated for 1 h.
Subsequently, the resulting “B. cereus-IMB” complexes
reacted with IMLNs for one hour to form “IMLN-B.
cereus-IMB” complexes; this reaction was followed by
lysis of the conjugated IMLNs to release encapsulated SRB
dye molecules. The intensity of the Xuorescence signals of
the spiked samples increased with the IMB volume. How-
ever, the background signal also increased as the IMB vol-
umes increased. Hence, tests with higher IMB volumes (20
and 40 L) gave lower S/N ratios (2.0 and 1.5). The test
with 10 L IMB gave the highest S/N ratio (6.6). However,
reducing IMB volume to 5 L signiWcantly reduced about
40% of the S/N ratio to 4.0, compared to that of 10 L
IMB. This result might possibly be due to this lower
amount of “B. cereus-IMB” complexes was unable to
capture large amount of IMLNs. Therefore, 10 L IMB was
selected for further study to maximize the S/N ratio.
Optimization of immunoliposomes
Once the optimal conditions for IMB had been identiWed,
the working conditions for IMLNs, which are the detection
reagent in this developed assay, were optimized. These
conditions included dilution buVer, and the size, the molar
percentage (mol%) of surface-tagged antibodies, and con-
centration of immunoliposomal nanovesicles (IMLNs).
TBS and TBST, which is TBS that contains 0.005% Tri-
ton X-100, were used in an attempt to Wnd a better buVer
for diluting immunoliposomes. Triton X-100 is a nonionic
surfactant with an average molecular weight of »800 Da,
which is commonly used as a gentle detergent in immuno-
assays to prevent nonspeciWc interactions. Additionally, a
lower concentration of Triton X-100 is used in this optimi-
zation to prevent the lysis of IMLNs during incubation
[39]. Figure 4 demonstrates that TBST not only reduced the
intensity of the Xuorescence signals of unspiked samples
but also concurrently reduced the intensity of the Xuores-
cence signals of spiked samples, such that the S/N ratio of
TBST (1.19 § 0.03) was signiWcantly lower than that of
TBS (2.11 § 0.23). Hence, TBS was chosen as the optimal
dilution buVer for IMLNs in subsequent study.
In the next step, the size of IMLNs was optimized. Lipo-
somal nanovesicles with various diameters were prepared
by extrusion through polycarbonate membranes with pores
of sizes 0.6, 0.4 and 0.2 m yielded liposomal nanovesicles
with diameters of 550, 300 and 200 nm, as determined
using a particle size analyzer. In Fig. 5, each batch of
IMLNs was adjusted to a total lipid concentration of
100 nmol/mL, before they were applied to the IMB/IMLN
assay. IMLN with a diameter of 300 nm yielded the stron-
gest Xuorescence signal, with target B. cereus concentra-
tions from 0 to 107 CFU/mL. Moreover, its intensity of
Xuorescence signals increased as the increase of B. cereus
concentration. However, IMLN with a diameter of 550 nm
Fig. 3 Optimization of amount of IMB for unspiked sample and
sample spiked with 108 CFU/mL of B. cereus in an IMB/IMLN
Xuorescence assay. DiVerent amounts of IMBs were incubated with
1 mL of unspiked sample or sample spiked with 108 CFU/mL of
B. cereus in 2 mL eppendorf tubes for 1 h at 37 °C. Assay was per-
formed as described in “Materials and methods”
Fig. 4 EVect of dilution buVer of IMLN on Xuorescence signals and
signal-to-noise ratios of unspiked sample and samples spiked with
108 CFU/mL of B. cereus in IMB/IMLN Xuorescence assay123
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rescence signals from spiked samples over that from unspi-
ked samples. Rather, a notable decline in the intensity of
the signals was observed, from both spiked and unspiked
samples. This drop in the signal intensity may have been
caused by the steric hindrance or steric resistance of larger
IMLNs, which reduced the number of IMLNs that could
reach and conjugate to the “B. cereus-IMBs” complexes
[42]. When 200 nm IMLN was used, the signal intensity
clearly decreased. This signal decline may have been
caused by the reduction in the number of encapsulated SRB
molecules in the IMLNs with a smaller diameter. The
results of Fig. 5 revealed 300 nm was the optimal diameter
for generating IMLNs, which maximized the intensity of
Xuorescence signal from the spiked samples with a wide
dynamic range.
The next step of the optimization of IMLN focused on
the conjugated antibody mol% on the liposomal surface.
The aYnity between B. cereus and immunoliposomes
depends on the mol% of tagged anti-B. cereus antibody.
Three diVerent antibody mol% were tested: 0.125, 0.25
and 0.5 mol%, as shown in Fig. 6. The S/N ratios increased
as the antibody mol% increased from 0.125 to 0.25 mol%.
However, when the antibody mol% reached 0.5 mol%, the
S/N ratio signiWcantly reduced more than 40%, compared
to that of 0.25 mol%. If too many tagged antibodies are
present on over a limited surface area of immunolipo-
somes, they may be too crowded to provide suYcient
space to allow the antigens (B. cereus) to orientate in a
manner that allows them to interact with the Fab region of
antibodies. Therefore, less B. cereus was captured, and so
fewer immunoliposomes were bound. Moreover, in testing
a series of concentrations of B. cereus (101, 103 and
105 CFU/mL), 0.25 mol% antibody-tagged immunolipo-
somes provided a wider dynamic range than 0.125 and
0.5 mol% antibody-tagged immunoliposomes (data not
shown). Hence, 0.25 mol% antibody-tagged immunolipo-
some was selected for further study.
The Wnal step for optimizing IMLNs was to Wnd the
working concentration that maximized the S/N ratio.
Immunoliposomal nanovesicles with a 300 nm diameter
and 0.25 mol% of tagged antibody were diluted into total
lipid concentrations of 50, 100 and 150 nmol/mL, before
they were used in the developed IMB/IMLN assay. Among
three spiked samples (101, 102 and 103 CFU/mL B. cereus),
a total lipid concentration of 100 nmol/mL gave the highest
S/N ratio, as presented in Fig. 7. The S/N ratios of samples
treated with three IMLN concentrations all increased with
the increasing amount of B. cereus. The S/N ratios for vari-
ous IMLN concentrations in the spiked samples followed
the order: 100 > 50 > 150 nmol/mL. When 150 nmol/mL of
IMLN was used, the intensity of Xuorescence signal of the
spiked samples increased but the background signal also
increased more rapidly. Therefore, 150 nmol/mL of IMLN
yielded a lower S/N value than 100 nmol/mL of IMLN. In
conclusion, a total lipid concentration of 100 nmol/mL was
utilized in the developed assay.
SpeciWc analysis
The performance of an immunoassay depends greatly on
the aYnity and speciWcity of the antigen–antibody interac-
tion [43, 44]. However, the cross-reactivity of the antibody
reduces the speciWcity of immunoassays. Since the antibod-
ies used in this developed assay were polyclonal, speciWcity
had to be evaluated. The speciWcity test was conducted by
determining the strength of the signal that was produced in
the spiked samples, as all of the bacteria were diluted to
103 CFU/mL. In Fig. 8, the sample spiked with B. cereus
had a higher S/N value (2.5) that diVered signiWcantly from
that of other Gram positive and negative bacteria, whose
Fig. 5 EVect of IML size on Xuorescence signals from unspiked sam-
ple and samples spiked with various amounts of B. cereus (102, 105,
and 107 CFU/mL) in IMB/IMLN Xuorescence assay
Fig. 6 Optimization of tagged antibody mol% on surface of IMLN for
unspiked sample and sample spiked with 105 CFU/mL of B. cereus in
an IMB/IMLN Xuorescence assay. IMLNs used herein were normal-
ized to a total lipid concentration of 100 nmol/mL before incubation
with “IMB-B. cereus” complexes123
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false positive result was obtained for B. subtilis. This result
was in fact expected since the antibodies utilized in this
assay were polyclonal and so may have exhibited slight
cross-reactivity with other Bacillus species. The speciWcity
results demonstrate that the anti-B. cereus antibodies uti-
lized in this assay were highly speciWc for detecting B.
cereus.
Assay performance
The developed assay is based on a sandwich format with
IMBs as the capture reagent, to catch B. cereus and IMLNs
as the detection reagents, to reveal the captured B. cereus.
More B. cereus in samples resulted in more “IMB-B.
cereus-IMLN complexes”, and therefore, the release of
more encapsulated SRB molecules in IMLNs to yield a
higher intensity of Xuorescence signal. To evaluate the
applicability of this developed method, B. ceruse was
detected using various concentrations (0–107 CFU/mL) in
sterile skimmed milk. The LOD of this developed assay
was determined from the dose-response curve (Fig. 9).
According to the International Union of Pure and Applied
Chemistry (IUPAC), LOD in this study was deWned as the
concentration that corresponds to the mean of the intensity
of Xuorescence signal in unspiked samples plus three stan-
dard divisions (SD). The dose-response curve yielded a
three -parameter sigmoid function, with an R2 value of
0.9979. The dynamic range of this curve was approxi-
mately from 0 to 103 CFU/mL, and the calculated LOD
value was nearly 5 CFU/mL. To testify the false negative
result of this developed assay, 10 CFU/mL of B. cereus was
spiked in two sets of 20 parallel assays in the PB and milk,
respectively. For the spiked PB samples, the number of
positive tests was 18 and the number of negative tests was
two. Hence, its false negative value was 10%. Moreover,
for the spiked milk samples, the number of positive tests
was 20. Therefore, its false negative value was 0% and
yielded a test sensitivity of 100% (data not shown). The
reason of milk samples had higher sensitivity than PB sam-
ples might be due to the nutrients in milk which were able
to enhance the growth of B. cereus during the Wrst hour of
the assay time. Consequently, the spiked milk sample could
provide higher signal intensity than the spiked PB sample
when both samples were spiked with 10 CFU/mL of B.
cereus.
Conclusion
A simple, rapid and sensitive immunoassay method based
on an IMB-IMLN system was developed to detect B.
cereus in milk. It involves the immobilization of capture
Fig. 7 EVect of IMLN concentration on signal-to-noise ratio of sam-
ples spiked with diVerent concentrations of B. cereus. IMLNs at total
lipid concentrations of 50, 100 or 150 nmol/mL were added to 2 mL
eppendorf tubes that contained IMBs conjugated with various amounts
of B. cereus (101, 102 and 103 CFU/mL)
Fig. 8 SpeciWcity of IMB/IMLN Xuorescence assay. The signal-to-
noise ratios of ten food-born bacteria were measured using 103 CFU/
mL in developed IMB/IMLN Xuorescence assay. Data labeled with
various superscripts diVered signiWcantly (p < 0.05)
Fig. 9 Dose-response curves for the samples spiked with serial dilu-
tion of B. cereus in IMB/IMLN Xuorescence assay. Solid line is a third
order polynomial curve with an R2 value of 0.9979. The gray line rep-
resents the limit of detection (LOD); deWned as mean of the intensity
of Xuorescence signal for unspiked sample plus three SDs, calculated
as 5 CFU/mL of B. cereus123
80 Eur Food Res Technol (2009) 229:73–81antibody on the surface of magnetic beads, the use of IMBs
to capture B. cereus from sample solutions, and the
measurement of Xuorescence signals from released SRB
molecules that are encapsulated by anti-B. cereus antibody-
tagged IMLNs. The results suggested that the IMBs were
optimally prepared by incubating 175 g/mL of anti-B.
cereus antibody with 100 L of protein A magnetic beads.
To prevent non-speciWc interactions, the wash buVer that
was applied in this assay was Tris-buVered saline that
contained Tween 20 (TBST) with a pH value of eight and
an osmolality of 530 mmol/kg, adjusted by adding sucrose.
In the developed assay, 10 L of IMBs was incubated with
samples for 1 h, and then the captured B. cereus was
detected using 100 nmol/mL IMLNs with a diameter of
300 nm and a surface-tagged antibody mol% of 0.25 mol%.
The entire IMB/IMLN assay was completed in <4 h and
had an LOD value of close to 5 CFU of B. cereus/mL in
milk without the pre-enrichment and with a test sensitivity
of 100% (20/20). The extreme sensitivity of the assay was
caused by the encapsulation of high concentrations of SRB
Xuorescent molecules in the anti-B. cereus antibody-tagged
IMLNs. The extreme sensitivity of IMLNs was such that
only 1 h of enrichment suYced to form the required number
of “IMB-B. cereus complexes” for detection. The use of
this procedure is expected to reduce the assay time in which
B. cereus may be identiWed in aqueous samples that are
associated with epidemiological investigations. It may thus
increase the speed with which health care facilities and the
population may be alerted of possible health threats.
Finally, it is necessary to re-optimize the protocol of this
developed assay for other food matrix. When preparation
for other kind of liquid, solid or thick foods, they possibly
require to isolate the small number of B. cereus present in
the suspected food with a stomacher or a blender. This sam-
ple preparation step might signiWcant aVect the recovery
rate of B. cereus from food samples and decrease the assay
sensitivity. In addition, food matrix might aVect the interac-
tions between antibody and antigen in the immunoassays,
resulted in the reduction of the signal intensity in the assay.
Therefore, it is recommended to re-optimize the protocol
for other food matrix for immunoassays [45].
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